Lyra Therapeutics, Inc.
LYRADelisted Apr 20, 2026- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001327273
Lyra Therapeutics, Inc. was delisted on Apr 20, 2026; its insiders filed their last Form 4 on May 15, 2026; 23 institutions reported holding it in 13F filings for Q4 2025, worth $747.3K in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Lyra Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- −9 vs. Q2 2021
- Shares held
- 6.67M
- −313.2K (−4.5%) vs. Q2 2021
- Total value
- $60.8M
- +$4.80M (+8.6%) vs. Q2 2021
- New holders
- 3
- 7 more added
- Sold out
- 12
- 16 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LYRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $51.1K |
| Q4 2025 | 23 | $747.3K |
| Q3 2025 | 26 | $2.93M |
| Q2 2025 | 30 | $4.42M |
| Q1 2025 | 57 | $3.23M |
| Q4 2024 | 54 | $5.54M |
| Q3 2024 | 62 | $8.36M |
| Q2 2024 | 51 | $9.06M |
| Q1 2024 | 79 | $283.4M |
| Q4 2023 | 60 | $222.0M |
| Q3 2023 | 45 | $124.8M |
| Q2 2023 | 39 | $138.4M |
| Q1 2023 | 31 | $38.1M |
| Q4 2022 | 37 | $59.9M |
| Q3 2022 | 38 | $96.0M |
| Q2 2022 | 38 | $108.9M |
| Q1 2022 | 28 | $20.2M |
| Q4 2021 | 34 | $22.4M |
| Q3 2021 | 37 | $60.8M |
| Q2 2021 | 46 | $56.0M |
| Q1 2021 | 50 | $87.6M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Lyra Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 18 | $0 | 0.00% | −549−96.8% | Reduced |
| JPMorgan Chase & Co | 34 | $0 | 0.00% | 00.0% | Unchanged |
| Investors Research Corp | 15 | $0 | 0.00% | 00.0% | Unchanged |
| Koshinski Asset Management, Inc. | 200 | $1.82K | 0.00% | +200 | New |
| Harbour Investments, Inc. | 175 | $2.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 287 | $3.00K | 0.00% | −109−27.5% | Reduced |
| US Bancorp | 500 | $5.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 537 | $5.00K | 0.00% | +14+2.7% | Added |
| Laurel Wealth Advisors LLC | 500 | $5.00K | 0.00% | 00.0% | Unchanged |
| Cardinal Capital Management, Inc. | 650 | $6.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,234 | $12.0K | 0.00% | −3,200−72.2% | Reduced |
| Tower Research Capital LLC (TRC) | 4,235 | $38.0K | 0.00% | +2,838+203.1% | Added |
| Close Asset Management Ltd | 7,000 | $64.0K | 0.00% | +7,000 | New |
| Trexquant Investment LP | 11,085 | $101.0K | 0.01% | −525−4.5% | Reduced |
| Marshall Wace, LLP | 12,457 | $114.0K | 0.00% | −6,864−35.5% | Reduced |
| Two Sigma Investments, LP | 13,384 | $122.0K | 0.00% | −10,500−44.0% | Reduced |
| Susquehanna International Group, LLP | 15,895 | $145.0K | 0.00% | −5,634−26.2% | Reduced |
| Ergoteles LLC | 16,273 | $149.0K | 0.01% | −14,727−47.5% | Reduced |
| BlackRock Inc. | 17,818 | $163.0K | 0.00% | −2,302−11.4% | Reduced |
| Morgan Stanley | 30,163 | $275.0K | 0.00% | −55,248−64.7% | Reduced |
| Pentwater Capital Management LP | 32,014 | $292.0K | 0.00% | +8,214+34.5% | Added |
| Geode Capital Management, LLC | 36,018 | $329.0K | 0.00% | −84−0.2% | Reduced |
| Boothbay Fund Management, LLC | 39,200 | $358.0K | 0.01% | −43,955−52.9% | Reduced |
| Ensign Peak Advisors, Inc | 39,167 | $358.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 58,000 | $529.0K | 0.00% | +14,000+31.8% | Added |
| Bridgeway Capital Management, LLC | 68,900 | $630.0K | 0.01% | +27,000+64.4% | Added |
| Deutsche Bank AG | 76,352 | $697.0K | 0.00% | −89−0.1% | Reduced |
| Bank of America Corp | 110,511 | $1.01M | 0.00% | +79,524+256.6% | Added |
| Millennium Management LLC | 118,158 | $1.08M | 0.00% | −36,977−23.8% | Reduced |
| Parian Global Management LP | 121,300 | $1.11M | 0.79% | +121,300 | New |
| ArrowMark Colorado Holdings LLC | 139,187 | $1.27M | 0.01% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 215,576 | $1.97M | 0.31% | +32,500+17.8% | Added |
| Vanguard Group Inc | 220,029 | $2.01M | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 403,450 | $3.69M | 0.84% | −221,234−35.4% | Reduced |
| Pura Vida Investments, LLC | 533,417 | $4.87M | 0.37% | −9,227−1.7% | Reduced |
| Polaris Venture Management Co. V, L.L.C. | 1,100,852 | $10.0M | 71.28% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 3,222,560 | $29.4M | 0.43% | 00.0% | Unchanged |
| Blair William & Co | 0 | $0 | 0.00% | −55,000−100.0% | Sold out |
| Tibra Equities Europe Ltd | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −31,539−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −19,381−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −19,093−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −18,602−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −10,751−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −62−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| Toth Financial Advisory Corp | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |